Who are the key players in Arbovirus Testing Market?

Agilent Technologies, Inc. , Thermo Fisher Scientific , NovaTec Immundiagnostica GmbH , Euroimmun AG and Abbott Laboratories are the major companies operating in the Arbovirus Testing Market. Read More

Which is the fastest growing region in Arbovirus Testing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Arbovirus Testing Market?

In 2024, the North America accounts for the largest market share in Arbovirus Testing Market. Read More

What years does this Arbovirus Testing Market cover, and what was the market size in 2023?

In 2023, the Arbovirus Testing Market size was estimated at USD 0.81 billion. The report covers the Arbovirus Testing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Arbovirus Testing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Arbovirus Testing Market Size

Market Size of Arbovirus Testing Industry

Study Period	2019 - 2029
Market Size (2024)	USD 0.86 Billion
Market Size (2029)	USD 1.14 Billion
CAGR (2024 - 2029)	5.92 %
Fastest Growing Market	Asia Pacific
Largest Market	North America
Market Concentration	Medium
Major Players *Disclaimer: Major Players sorted in no particular order

Arbovirus Testing Market Analysis

The Arbovirus Testing Market size is estimated at USD 0.86 billion in 2024, and is expected to reach USD 1.14 billion by 2029, growing at a CAGR of 5.92% during the forecast period (2024-2029).

The major factors accounting for the growth of the arbovirus testing market are the increasing rate of incidence and prevalence of Arbovirus throughout the world, recent advancements in technology, and emerging rapid Serology Tests that may drive the arbovirus testing market during the forecast period.
For example, WHO has reported that the number of dengue cases reported increased over 15-fold over the last two decades, from 505,430 cases in 2000 to over 2,400,138 in 2010 and 3,312,040 in 2015. Deaths from 2000 to 2015 increased from 960 to more than 4032, which strongly supports the increase in the incidence of arboviral diseases.
Thus, the incidence rate of Arboviral diseases drives the growth of the arbovirus testing market during the forecast period. However, the lack of in vitro facilities, lack of awareness, and limited availability of diagnostic testing procedures may restrain the studied market's growth during the forecast period.

Arbovirus Testing Industry Segmentation

Arboviruses (Arthropod-borne viruses) are a unique, diverse, and fascinating group of viruses because they cycle between a wide variety of vertebrate hosts and arthropod species. Examples of the arboviral infectious diseases include Dengue, Chikungunya, St. Louis encephalitis, Yellow fever, California encephalitis, Eastern Equine Encephalitis, Powassan, West Nile, and Zika.

By Test Type
		ELISA-based Tests
		RT-PCR based Tests
		Other Test Types

By End User
		Diagnostic Laboratories
		Hospitals
		Research Centers
		Other End Users

By Geography

North America
	United States
	Canada
	Mexico

Europe
	Germany
	United Kingdom
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle East & Africa
	GCC
	South Africa
	Rest of Middle East & Africa

South America
	Brazil
	Argentina
	Rest of South America

Need A Different Region Or Segment?

Customize Now

Arbovirus Testing Market Size Summary

The arbovirus testing market is poised for significant growth, driven by the increasing incidence and prevalence of arboviral diseases globally. Technological advancements and the emergence of rapid serology tests are key factors propelling market expansion. The rising number of dengue cases, as reported by the WHO, underscores the growing demand for effective testing solutions. Despite these growth drivers, challenges such as limited in vitro facilities, lack of awareness, and restricted availability of diagnostic procedures may hinder market progress. The RT-PCR based tests segment is anticipated to lead the market due to its superior detection limits and sensitivity compared to ELISA methods, along with reduced laboratory waste.

Regionally, North America is expected to maintain its dominance in the arbovirus testing market, supported by a developed economy, increased healthcare spending, and the adoption of advanced technological products. Meanwhile, the Asia-Pacific region is projected to experience a high growth rate, attributed to its dense population, which facilitates the spread of arboviral diseases. The market is moderately competitive, with major players like Agilent Technologies Inc., Thermo Fisher Scientific, and Abbott Laboratories driving innovation and competition. The ongoing consolidation and product recalls in the healthcare sector are likely to intensify competitive rivalry among key market participants.

Explore More

Arbovirus Testing Market Size - Table of Contents

1. MARKET DYNAMICS
1. 1.1 Market Overview
2. 1.2 Market Drivers
  1. 1.2.1 Increase in the Incidence and Prevalence of Arbovirus
  2. 1.2.2 Advancement in Technology
  3. 1.2.3 Rapid Serology Tests
3. 1.3 Market Restraints
  1. 1.3.1 Lack of In vitro Facilities
  2. 1.3.2 Lack of Awareness and Limited Availability of Diagnostic Testing Procedures
4. 1.4 Porter's Five Forces Analysis
  1. 1.4.1 Threat of New Entrants
  2. 1.4.2 Bargaining Power of Buyers/Consumers
  3. 1.4.3 Bargaining Power of Suppliers
  4. 1.4.4 Threat of Substitute Products
  5. 1.4.5 Intensity of Competitive Rivalry
2. MARKET SEGMENTATION
1. 2.1 By Test Type
  1. 2.1.1 ELISA-based Tests
  2. 2.1.2 RT-PCR based Tests
  3. 2.1.3 Other Test Types
2. 2.2 By End User
  1. 2.2.1 Diagnostic Laboratories
  2. 2.2.2 Hospitals
  3. 2.2.3 Research Centers
  4. 2.2.4 Other End Users
3. 2.3 By Geography
  1. 2.3.1 North America
    1. 2.3.1.1 United States
    2. 2.3.1.2 Canada
    3. 2.3.1.3 Mexico
  2. 2.3.2 Europe
    1. 2.3.2.1 Germany
    2. 2.3.2.2 United Kingdom
    3. 2.3.2.3 France
    4. 2.3.2.4 Italy
    5. 2.3.2.5 Spain
    6. 2.3.2.6 Rest of Europe
  3. 2.3.3 Asia-Pacific
    1. 2.3.3.1 China
    2. 2.3.3.2 Japan
    3. 2.3.3.3 India
    4. 2.3.3.4 Australia
    5. 2.3.3.5 South Korea
    6. 2.3.3.6 Rest of Asia-Pacific
  4. 2.3.4 Middle East & Africa
    1. 2.3.4.1 GCC
    2. 2.3.4.2 South Africa
    3. 2.3.4.3 Rest of Middle East & Africa
  5. 2.3.5 South America
    1. 2.3.5.1 Brazil
    2. 2.3.5.2 Argentina
    3. 2.3.5.3 Rest of South America